Stay updated on AZD4785 Phase I Dose-Escalation Clinical Trial

Sign up to get notified when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AZD4785 Phase I Dose-Escalation Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error for the study record.
    Difference
    1%
    Check dated 2026-10-26T14:57:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:45:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:50:48.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error and minimal header elements, instead of displaying the full study record content.
    Difference
    18%
    Check dated 2026-09-21T20:34:44.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating an updated version of the page.
    Difference
    0.1%
    Check dated 2026-08-31T18:32:41.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 appears, replacing the previous v3.6.4. This indicates a site update; there are no evident changes to the study content or ClinicalTrials.gov page details.
    Difference
    0.1%
    Check dated 2026-08-10T12:32:41.000Z thumbnail image

Stay in the know with updates to AZD4785 Phase I Dose-Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.